High risk of cardiovascular disease in patients with type 1 diabetes in the UK - A cohort study using the General Practice Research Database

被引:303
作者
Soedamah-Muthu, SS
Fuller, JH
Mulnier, HE
Raleigh, VS
Lawrenson, RA
Colhoun, HM
机构
[1] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands
[2] Royal Free & UCL, Sch Med, Dept Epidemiol & Publ Hlth, London, England
[3] Univ Surrey, Postgrad Med Sch, Guildford GU2 5XH, Surrey, England
[4] Healthcare Commiss, London, England
[5] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland
关键词
D O I
10.2337/diacare.29.04.06.dc05-1433
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To estimate the absolute and relative risk of cardiovascular disease (CVD) in patients With type 1 diabetes in the U.K. RESEARCH DESIGN AND METHODS - Subjects with type I diabetes (n = 7,479) and five age- and sex-matched subjects without diabetes (n = 38,116) and free of CVD at baseline were selected from the General Practice Research Database (GPRD), a large primary care database representative of the U.K. population. Incident major CVD events, Comprising myocardial infarction, acute coronary heart disease death, coronary revascularizations, or stroke, were captured for the period 1992-1999. RESULTS - The hazard ratio (HR) for major CVD was 3.6 (95% CI 2.9-4.5) in type I diabetic men compared with those without diabetes and 7.7 (5.5-10.7) in women. Increased HRs were found for acute coronary events (3.0 and 7.6 in type 1. diabetic men and women, respectively, versus nondiabetic subjects), coronary revascularizaitons (5.0 in men, 16.8 in women), and for stroke (3.7 in men, 4.8 in women). Type 1 diabetic men aged 45-55 years had an absolute CVD risk similar to that of men in the general population 10-15 years older, with an even greater difference in women. CONCLUSIONS - Despite advances in care, these data show that absolute and relative risks of CVD remain extremely high in patients with type 1 diabetes. Women with type 1 diabetes continue to experience greater relative risks of CVD than men compared with those without diabetes.
引用
收藏
页码:798 / 804
页数:7
相关论文
共 28 条
[1]  
[Anonymous], 1994, Pharmacoepidemiology) and Drug Safety
[2]  
Clayton D., 1993, STAT MODELS EPIDEMIO
[3]   Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes [J].
Colhoun, HM ;
Otvos, JD ;
Rubens, MB ;
Taskinen, MR ;
Underwood, SR ;
Fuller, JH .
DIABETES, 2002, 51 (06) :1949-1956
[4]   Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].
Colhoun, HM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Livingstone, SJ ;
Thomason, MJ ;
Mackness, MI ;
Charlton-Menys, V ;
Fuller, JH .
LANCET, 2004, 364 (9435) :685-696
[5]   The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification [J].
Colhoun, HM ;
Rubens, MB ;
Underwood, SR ;
Fuller, JH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2160-2167
[6]   European guidelines on cardiovascular disease prevention in clinical practice -: Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts) (vol 171, pg 145, 2003) [J].
De Backer, G ;
Ambrosioni, E ;
Borch-Johnsen, K ;
Brotons, C ;
Cifkova, R ;
Dallongeville, J ;
Ebrahim, S ;
Faergeman, O ;
Graham, I ;
Mancia, G ;
Cats, VM ;
Orth-Gomér, K ;
Perk, J ;
Pyörälä, K ;
Rodicio, JL ;
Sans, S ;
Sansoy, V ;
Sechtem, U ;
Silber, S ;
Thomsen, T ;
Wood, D .
ATHEROSCLEROSIS, 2004, 173 (02) :379-391
[7]   Risk factors for cardiovascular mortality and morbidity: The WHO multinational study of vascular disease in diabetes. [J].
Fuller, JH ;
Stevens, LK ;
Wang, SL .
DIABETOLOGIA, 2001, 44 (Suppl 2) :S54-S64
[8]  
Genuth S, 1999, DIABETES CARE, V22, P99
[9]  
Hollowell J, 1997, Popul Trends, P36
[10]  
JICK H, 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607